Comparative pharmacokinetics of cefamandole, cephapirin, and cephalothin in healthy subjects and effect of repeated dosing. 1976

M Barza, and S Melethil, and S Berger, and E C Ernst

Cefamandole nafate, cephapirin, and cephalothin were administered intravenously in crossover fashion to 12 volunteers, in dosages of 2 g every 6 h for 16 doses. Mean peak levels of cefamandole were approximately 50% higher than those of the other agents. The serum concentration curves appeared to decline bi-exponentially, suggesting that a two-compartment model was most applicable for pharmacokinetic analysis; accordingly, the t((1/2)) of cefamandole was significantly longer when the serum peak was omitted from the analysis (0.86 versus 0.73 h, P < 0.05). The half-lives of cephalothin and cephapirin, 0.34 and 0.36 h, respectively, were probably underestimates reflecting the inclusion of distribution-phase values in the calculation. Repeated dosing had no effect on the peak serum levels, half-life, serum clearance, or apparent volume of distribution with one exception: peak serum levels of cephapirin were significantly lower after the sixteenth than after the first dose. Marked variations within a given subject were noted in the half-life and apparent volume of distribution of cefamandole in several instances. Renal clearances of cefamandole exhibited saturation kinetics similar to those of penicillin G.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008333 Mandelic Acids Analogs or derivatives of mandelic acid (alpha-hydroxybenzeneacetic acid). Acids, Mandelic
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002512 Cephalothin A cephalosporin antibiotic. Cefalotin,Sodium Cephalothin,Cefalotina Normon,Cefalotina Sodica Spaly,Ceftina,Cephalothin Monosodium Salt,Keflin,Seffin,Cephalothin, Sodium,Monosodium Salt, Cephalothin,Salt, Cephalothin Monosodium
D002514 Cephapirin Cephalosporin antibiotic, partly plasma-bound, that is effective against gram-negative and gram-positive organisms. BL-P 1322,Brisfirina,Cefadyl,Cefapirin,Cephapirin Monosodium Salt,Cephapirin Sodium,Céfaloject,Sodium Cephapirin,BL P 1322,BLP 1322,Cephapirin, Sodium,Monosodium Salt, Cephapirin,Salt, Cephapirin Monosodium
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Barza, and S Melethil, and S Berger, and E C Ernst
April 1976, Antimicrobial agents and chemotherapy,
M Barza, and S Melethil, and S Berger, and E C Ernst
November 1987, Clinical pharmacy,
M Barza, and S Melethil, and S Berger, and E C Ernst
March 2001, International journal of clinical pharmacology and therapeutics,
M Barza, and S Melethil, and S Berger, and E C Ernst
July 1982, International journal of clinical pharmacology, therapy, and toxicology,
M Barza, and S Melethil, and S Berger, and E C Ernst
January 1978, Scandinavian journal of infectious diseases. Supplementum,
M Barza, and S Melethil, and S Berger, and E C Ernst
February 1981, Antimicrobial agents and chemotherapy,
M Barza, and S Melethil, and S Berger, and E C Ernst
April 1980, American journal of obstetrics and gynecology,
M Barza, and S Melethil, and S Berger, and E C Ernst
January 1977, Current therapeutic research, clinical and experimental,
M Barza, and S Melethil, and S Berger, and E C Ernst
January 1990, European journal of drug metabolism and pharmacokinetics,
M Barza, and S Melethil, and S Berger, and E C Ernst
January 1988, Fundamental & clinical pharmacology,
Copied contents to your clipboard!